Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Avenoso, Daniele
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Robin M
,
Iacobelli S
,
Koster L
,
Passweg J
,
Avenoso D
,
Wilson KMO
,
Salmenniemi U
,
Dreger P
,
Borne Pvon dem
,
Snowden JA
, et al.
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant. 2024.
PubMed
Google Scholar
E
Penack O
,
Peczynski C
,
Boreland W
,
Lemaitre J
,
Afanasyeva K
,
Kornblit B
,
Jurado M
,
Martínez C
,
Natale A
,
Pérez-Simón JAntonio
, et al.
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.
Front Immunol. 2023;14:1283034.
PubMed
Google Scholar
Penack O
,
Peczynski C
,
Boreland W
,
Lemaitre J
,
H Reinhardt C
,
Afanasyeva K
,
Avenoso D
,
Holderried TAW
,
Kornblit BThomas
,
Gavriilaki E
, et al.
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.
Bone Marrow Transplant. 2024.
PubMed
Google Scholar
H
Avenoso D
,
Serpenti F
,
Slonim LBarnea
,
Bouziana S
,
Dazzi F
,
Hannah G
,
Kenyon M
,
Mehra V
,
Kulasekararaj A
,
Krishamurthy P
, et al.
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy.
Mediterr J Hematol Infect Dis. 2024;16(1):e2024002.
PubMed
Google Scholar
O
Ortí G
,
Gras L
,
Zinger N
,
Finazzi MChiara
,
Sockel K
,
Robin M
,
Forcade E
,
Avenoso D
,
Kröger N
,
Finke J
, et al.
Outcomes after Allogeneic Hematopoietic Cell Transplant in patients diagnosed with Blast Phase of Myeloproliferative Neoplasms: a retrospective study from the Chronic Malignancies Working Party of the EBMT.
Am J Hematol. 2023.
PubMed
Google Scholar
R
Devillier R
,
Galimard J-E
,
Labopin M
,
Blaise D
,
Raiola AMaria
,
Pavlu J
,
Castagna L
,
Socié G
,
Chalandon Y
,
Martino M
, et al.
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT.
Bone Marrow Transplant. 2022.
PubMed
Google Scholar